speb/financial-data huggingface dataset:
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -7246000.00
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 7847000.00
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 470000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Net PPE: 87320000.00
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -7795000.00
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -50695000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 1014881000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Assets: 4368000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 8207000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 211000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 7885000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 7200000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 51842000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Normalized Income: 32216116.94
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -463315000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Operating Income: 40371000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Operating Revenue: 504394000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 24996000.00
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 2232000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: -1000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Other Inventories: -1000.00
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -1353000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 8793000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -1000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 7500000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 2728000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Other Payable: 9628000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Other Properties: 4613000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Payables: 69145000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 409031000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Pretax Income: 40611000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 0.00
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: 0.00
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -7795000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 97752000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 434980000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 2013000.00
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: 0.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 8000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 43750000.00
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 3136000.00
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 470000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1052000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 2143000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Share Issued: 24996000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Special Income Charges: -12000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 1014881000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 1014881000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -2883.06
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Tax Provision: 9757000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.24
ASHOKAMET.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: 0.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Total Assets: 1329791000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 1047506000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Total Debt: 157524000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 1064982000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Total Expenses: 464023000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 264809000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 299680000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 48716000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 278000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 459000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -12000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -12000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Trading Securities: 45458000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Work In Process: 3395000.00
ASHOKAMET.NS balance_sheet (annual, 2023-03-31) — Working Capital: 814018000.00
ASHOKAMET.NS income_statement (annual, 2023-03-31) — Write Off: 12000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — +Operating Expense: 45186000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — +Total Revenue: 662491000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 46319000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 262814000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -23077000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 107000000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 24996000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Basic EPS: 1.92
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 13803000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 25167000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -87990000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 249960000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 5052000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 5052000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 5052000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -24739000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 80813000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 34622000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Change In Payable: -12739000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 23556000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 99661000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 1252000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Common Stock: 249960000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 1045602000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 0.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 554670000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Current Assets: 949535000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Current Debt: 154134000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 154134000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 236123000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 15294000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Depreciation: 5223000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 5223000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 7421000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 7421000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 24996000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Diluted EPS: 1.92
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 47937000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — EBIT: 79376000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — EBITDA: 86797000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — End Cash Position: 15056000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -24516000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 240349000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Fixed Assets Revaluation Reserve: 0.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 70979000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -13053000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 2455000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Goodwill: 0.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 0.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 193165000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Gross Profit: 107821000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Interest Expense: 14479000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 14479000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Interest Income: 4430000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 4430000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -15263000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 0.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Inventory: 343413000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 1212101000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -133201000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 103721000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 6000000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 12365000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 12365000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 157385000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 67316000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Net Debt: 161447000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Net Income: 47937000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 47937000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 47937000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Net Income Discontinuous Operations: 0.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Net Income Extraordinary: 0.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 47937000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 47937000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 64897000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 47937000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Net Interest Income: -10838000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -45211000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -5412000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -5412000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -10838000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -3841000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Net PPE: 170088000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -87990000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 1045602000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Assets: 9368000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 8207000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 208000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 9623000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 1692000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 73744000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Normalized Income: 38295234.42
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 158969000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Operating Income: 62635000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Operating Revenue: 662491000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 24996000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 12059000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 14000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 795642000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 15263000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 7633000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 38208000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 47000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 8631000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Other Payable: 13826000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Other Properties: 4613000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Payables: 61785000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 316192000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Pretax Income: 64897000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -60000000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -87990000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 95946000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 554670000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 5223000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 10005000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 74471000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 14789000.00
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 0.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1781000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 4236000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Share Issued: 24996000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Special Income Charges: 0.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 1045602000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 1045602000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 3411234.42
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Tax Provision: 16960000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.26
ASHOKAMET.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -15219000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Total Assets: 1379237000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 1057967000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Total Debt: 166499000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 1112919000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Total Expenses: 599856000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 266318000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 429702000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 30195000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 789000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 1640000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 13053000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 13053000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Trading Securities: 103721000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Work In Process: 7118000.00
ASHOKAMET.NS balance_sheet (annual, 2024-03-31) — Working Capital: 713412000.00
ASHOKAMET.NS income_statement (annual, 2024-03-31) — Write Off: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 89896000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 361325000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 249960000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 6894000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 6894000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 249960000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 1082003000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 1028337000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 86956000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 86956000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 218136000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 16338000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 173266000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 410239000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 1184487000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 89071000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 15528000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 15528000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 81012000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 95590000.00
ASHOKAMET.NS income_statement (quarterly, 2024-09-30) — Net Income Extraordinary: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 173266000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 1082003000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 208000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 9623000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 24996000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 249879000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 24946000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 832043000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 21679000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 8207000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 173266000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Payables: 89896000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 24996000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 1082003000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 1082003000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 1414508000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 1097531000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 102484000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 1163014000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 251494000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 386171000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 33358000.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 810201000.00
ASHOKAMET.NS income_statement (quarterly, 2024-12-31) — Net Income Extraordinary: 0.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — +Operating Expense: 45126000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 8939000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — +Total Revenue: 389626000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 64904000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 50336000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 50336000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 261305000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 261305000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -29235000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -29235000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 107000000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 107000000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 24963265.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 24568182.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Basic EPS: 2.94
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.22
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 15056000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 25167000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 25167000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -16702000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 249960000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 249960000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 7987000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 7987000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 7987000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 7987000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 7987000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 7987000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -55464000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 9563000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -78498000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Change In Payable: 4017000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 1509000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -128199000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -7066000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Common Stock: 249960000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 249960000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 1114197000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1114197000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 15001000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 15001000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 313557000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 86576000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Current Assets: 986862000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 986862000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Current Debt: 81488000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 81488000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 81488000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 81488000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 152317000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 152317000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 5968000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 5968000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Depreciation: 6157000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 6157000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 6576000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: -1050000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 6576000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: -1050000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 24963265.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 24568182.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Diluted EPS: 2.94
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.22
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 73392000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 5405000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — EBIT: 95223000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — EBIT: 5941000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — EBITDA: 101799000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — EBITDA: 5941000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — End Cash Position: 7991000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 52963000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 304053000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 304053000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Fixed Assets Revaluation Reserve: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Fixed Assets Revaluation Reserve: 0.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -79367000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -26799000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 1193000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Goodwill: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 0.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 209867000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 209867000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Gross Profit: 76069000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Gross Profit: -21672000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Interest Expense: 15604000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 3740000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 15604000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 3740000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Interest Income: 121000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 121000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -15604000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Inventory: 398877000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 398877000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 1270507000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1270507000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: 2636000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 111182000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 111182000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 6000000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 6000000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 74822000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 74822000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 74822000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 74822000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 159047000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 159047000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 72114000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 72114000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Minority Interests: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Net Debt: 148323000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 148323000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Net Income: 73392000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Net Income: 5405000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 73392000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 5405000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 73392000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 5405000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Net Income Discontinuous Operations: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Net Income Extraordinary: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Net Income Extraordinary: 0.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 73392000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 5405000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 73392000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 5405000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 79619000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 73392000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 5405000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Net Interest Income: -15604000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -3740000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -7460000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 95414000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 95414000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -15604000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -3740000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -26847000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 26798000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Net PPE: 180632000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 180632000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -16702000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 1114197000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1114197000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Assets: 9368000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 9368000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 8207000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 8207000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 208000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 208000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 6924000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 6924000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 2643000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 2643000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 101799000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 5941000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Normalized Income: 73392000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 5405000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -62665000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Operating Income: 30943000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Operating Income: -30611000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Operating Revenue: 389626000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 64904000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 24996000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 24996000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 9084000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 9084000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 14000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 14000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 864236000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 864236000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 1000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 1000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 15483000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 34602000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 34602000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 8207000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 8207000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 64280000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 36552000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 26993000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 7007000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Other Payable: 7576000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 7576000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Other Properties: 4652000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 4652000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Payables: 61198000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Payables: 61198000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 309605000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 309605000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Pretax Income: 79619000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 2201000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -7460000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -16702000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 88091000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 88091000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 313557000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 86576000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 6157000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: -1050000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 4000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 4000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 143066000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 143066000.00
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 0.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1266000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 2459000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Share Issued: 24996000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 24996000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 1114197000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1114197000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 1114197000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1114197000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Tax Provision: 6227000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -3203000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.08
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
ASHOKAMET.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -8926000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Total Assets: 1428581000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 1428581000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 1189019000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1189019000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Total Debt: 156310000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 156310000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 1186311000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1186311000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Total Expenses: 358683000.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 95515000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 242270000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 242270000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 441718000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 441718000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 89953000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 89953000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 88000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 3286000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 3286000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Trading Securities: 111182000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Trading Securities: 111182000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Work In Process: 6732000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 6732000.00
ASHOKAMET.NS balance_sheet (annual, 2025-03-31) — Working Capital: 834545000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 834545000.00
ASHOKAMET.NS income_statement (annual, 2025-03-31) — Write Off: -36000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 22068000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 54539000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 25020000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.45
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 28777000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1486000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 1486000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 25020000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.45
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 11259000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — EBIT: 15111000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — EBITDA: 16597000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 25762000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 3852000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 3852000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Net Income: 11259000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 11259000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 11259000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 11259000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 11259000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 11259000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -3852000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -3852000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 16597000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 11259000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Operating Income: 3694000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 54539000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 11417000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 17699000.00